Format

Send to

Choose Destination

See 1 citation found by title matching your search:

Can J Physiol Pharmacol. 2017 Apr;95(4):455-458. doi: 10.1139/cjpp-2016-0338. Epub 2016 Nov 25.

Caffeine intake increases plasma ketones: an acute metabolic study in humans.

Author information

1
a Research Center on Aging, Sherbrooke, CIUSSS de l'Estrie - CHUS, QC J1H 4C4, Canada.
2
b Department of Pharmacology & Physiology, Université de Sherbrooke, Sherbrooke, QC J1K 2R1, Canada.
3
c Department of Medicine, Université de Sherbrooke, Sherbrooke, QC J1K 2R1, Canada.

Abstract

Brain glucose uptake declines during aging and is significantly impaired in Alzheimer's disease. Ketones are the main alternative brain fuel to glucose so they represent a potential approach to compensate for the brain glucose reduction. Caffeine is of interest as a potential ketogenic agent owing to its actions on lipolysis and lipid oxidation but whether it is ketogenic in humans is unknown. This study aimed to evaluate the acute ketogenic effect of 2 doses of caffeine (2.5; 5.0 mg/kg) in 10 healthy adults. Caffeine given at breakfast significantly stimulated ketone production in a dose-dependent manner (+88%; +116%) and also raised plasma free fatty acids. Whether caffeine has long-term ketogenic effects or could enhance the ketogenic effect of medium chain triglycerides remains to be determined.

KEYWORDS:

Alzheimer’s disease; acides gras libres; caffeine; caféine; cétones; cétonémie; free fatty acids; ketonemia; ketones; lipolyse; lipolysis; maladie d’Alzheimer; medium chain triglycerides; triglycérides à chaîne moyenne

PMID:
28177691
DOI:
10.1139/cjpp-2016-0338
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center